Before the pandemic, EMD Serono equipped its entire US salesforce with AI-powered recommendations to drive better HCP engagement. When COVID-19 hit, they were uniquely positioned to navigate the uncertainty of market change, transition to remote engagement and personalize the customer experience for overwhelmed HCPs.
The last few months have certainly tested the life sciences commercial process. While there’s still plenty of uncertainty about the future, one thing is for sure: the new omnichannel engagement model is more important than ever before.
Join this webinar to hear Joel VanderMeulen, Senior Director, N&I Commercial Strategy and Operations at EMD Serono, and Derek Choy, Co-founder and President at Aktana, discuss:
- Emerging market trends in the post-COVID world
- How commercial teams can adapt to the “next normal”
- The three key components for successful omnichannel engagement